E‐selectin targeting to visualize tumors<i>in vivo</i>
書誌事項
- 公開日
- 2010-03
- 資源種別
- journal article
- 権利情報
-
- http://onlinelibrary.wiley.com/termsAndConditions#vor
- DOI
-
- 10.1002/cmmi.367
- 公開者
- Wiley
この論文をさがす
説明
<jats:title>Abstract</jats:title><jats:p>Generally angiogenic factors induce the expression of E‐selectin in vascular endothelial cells in the tumors. In this study, we employed an anti‐E‐selectin monoclonal antibody to target tumors <jats:italic>in vivo</jats:italic> and evaluated an optical imaging reagent to visualize tumor regions. The anti‐E‐selectin antibody was conjugated on the surface of liposomes, which encapsulated the near‐infrared fluorescent substances Cy3 or Cy5.5. The liposomes efficiently recognized human umbilical vein endothelial cells only when E‐selectin was induced by angiogenic factors such as TNF‐<jats:italic>α</jats:italic> <jats:italic>in vitro</jats:italic>. Cy5.5 encapsulated into liposomes that were conjugated with an anti‐E‐selectin antibody successfully visualized Ehrlich ascites tumor cells when transplanted into mice. Thus, E‐selectin targeting with liposomes containing a near‐infrared fluorescent dye was found effective in visualizing tumors <jats:italic>in vivo</jats:italic>. This strategy should be extremely useful as a method to identify sentinel lymphatic nodes and angiogenic tumors as well as use for drug delivery to tumor cells. Copyright © 2010 John Wiley & Sons, Ltd.</jats:p>
収録刊行物
-
- Contrast Media & Molecular Imaging
-
Contrast Media & Molecular Imaging 5 (2), 70-77, 2010-03
Wiley
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1360004230068067968
-
- DOI
- 10.1002/cmmi.367
-
- ISSN
- 15554317
- 15554309
- http://id.crossref.org/issn/15554317
-
- PubMed
- 20235150
-
- 資料種別
- journal article
-
- データソース種別
-
- Crossref
- KAKEN
- OpenAIRE

